Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| EPIX Pharmaceuticals, Inc. | 518,206 | reported | 30 Jun 2009 | tx 18+880,283−245,818 |
| Climb Bio, Inc. | 40,000 | reported | 04 Jun 2025 | tx 2+120,000 |
| Acumen Pharmaceuticals, Inc. | 19,500 | reported | 04 Jun 2025 | tx 6+157,300 |
| LENZ Therapeutics, Inc. | 13,500 | reported | 11 Jun 2025 | tx 3+80,500 |
| Jounce Therapeutics, Inc. | 0 | reported | 03 May 2023 | tx 52+441,759−773,663 |
| PROTEOSTASIS THERAPEUTICS, INC. | 0 | reported | 30 Jun 2025 | tx 11+113,800−51,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 Jun 2025 | OTHER | PROTEOSTASIS THERAPEUTICS, INC. | 13,794 | — | |
| 30 Jun 2025 | OTHER | PROTEOSTASIS THERAPEUTICS, INC. | 20,000 | 0.00 USD | deriv |
| 23 Jun 2025 | EXERCISE | PROTEOSTASIS THERAPEUTICS, INC. | 12,500 | 0.61 USD | |
| 25 Jun 2025 | GRANT_AWARD | PROTEOSTASIS THERAPEUTICS, INC. | 6,000 | 0.00 USD | |
| 23 Jun 2025 | TAX_WITHHOLDING | PROTEOSTASIS THERAPEUTICS, INC. | 4,706 | 0.26 USD | |
| 23 Jun 2025 | EXERCISE | PROTEOSTASIS THERAPEUTICS, INC. | 12,500 | 0.00 USD | deriv |
| 11 Jun 2025 | GRANT_AWARD | LENZ Therapeutics, Inc. | 13,500 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Climb Bio, Inc. | 40,000 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Acumen Pharmaceuticals, Inc. | 12,800 | 0.00 USD | |
| 04 Jun 2025 | GRANT_AWARD | Acumen Pharmaceuticals, Inc. | 19,500 | 0.00 USD | deriv |
| 28 Mar 2025 | GRANT_AWARD | Climb Bio, Inc. | 80,000 | 0.00 USD | deriv |
| 04 Sept 2024 | GRANT_AWARD | PROTEOSTASIS THERAPEUTICS, INC. | 12,500 | 0.00 USD | deriv |
| 10 Jun 2024 | GRANT_AWARD | Acumen Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 21 Mar 2024 | GRANT_AWARD | LENZ Therapeutics, Inc. | 27,000 | 0.00 USD | deriv |
| 28 Jul 2023 | GRANT_AWARD | LENZ Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 01 Jul 2023 | GRANT_AWARD | PROTEOSTASIS THERAPEUTICS, INC. | 20,000 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | Acumen Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 03 May 2023 | TENDER | Jounce Therapeutics, Inc. | 40,267 | — | |
| 03 May 2023 | TENDER | Jounce Therapeutics, Inc. | 25,751 | — | |
| 03 May 2023 | OTHER | Jounce Therapeutics, Inc. | 8,130 | — | deriv |
| 03 May 2023 | OTHER | Jounce Therapeutics, Inc. | 77,235 | — | deriv |
| 03 May 2023 | OTHER | Jounce Therapeutics, Inc. | 97,500 | — | deriv |
| 03 May 2023 | OTHER | Jounce Therapeutics, Inc. | 44,500 | — | deriv |
| 03 May 2023 | OTHER | Jounce Therapeutics, Inc. | 53,400 | — | deriv |
| 03 May 2023 | OTHER | Jounce Therapeutics, Inc. | 44,500 | — | deriv |